Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -429 | -8,268 | 23,916 | -71,669 | -97,744 |
| Depreciation Amortization | 409 | 619 | 1,990 | 8,154 | 18,149 |
| Accounts receivable | 2,259 | 52 | 31,930 | -2,845 | -3,021 |
| Accounts payable and accrued liabilities | -437 | -2,110 | -952 | -7,434 | 111 |
| Other Working Capital | -1,969 | 2,053 | -15,619 | 8,008 | -1,153 |
| Other Operating Activity | -9,484 | -1,715 | -77,085 | 36,601 | 18,611 |
| Operating Cash Flow | $-9,651 | $-9,369 | $-35,820 | $-29,185 | $-65,047 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 15 | 8,500 | -8,500 |
| PPE Investments | -5 | -9 | -11 | -198 | -115 |
| Sale Of Investment | 2,000 | N/A | N/A | N/A | 475 |
| Other Investing Activity | -304 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,691 | $-9 | $4 | $8,302 | $-8,140 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,764 | 8,263 | 13,959 | 23,806 | 82,542 |
| Other Financing Activity | -447 | 154 | 7,480 | -12,353 | -9,080 |
| Financing Cash Flow | $7,317 | $8,417 | $21,439 | $11,453 | $73,462 |
| Exchange Rate Effect | -2 | 9 | -22 | -76 | -96 |
| Beginning Cash Position | 4,617 | 5,569 | 19,968 | 29,474 | 29,295 |
| End Cash Position | 3,971 | 4,617 | 5,569 | 19,968 | 29,474 |
| Net Cash Flow | $-646 | $-952 | $-14,399 | $-9,506 | $179 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,651 | -9,369 | -35,820 | -29,185 | -65,047 |
| Capital Expenditure | -5 | -9 | -11 | -198 | -115 |
| Free Cash Flow | -9,656 | -9,378 | -35,831 | -29,383 | -65,162 |